IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Caligan Partners LP

Q2 2026 Holdings

Filed 2026-08-14 | 28 holdings | $2.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Liquidia Corporation(LQDA)COM NEW53635D202$647.3M8,118,89230.5%
Revolution Medicines Inc(RVMD)COM76155X100$367.4M1,961,79517.3%
Abivax SA(ABVX)SPONSORED ADS00370M103$207.6M1,557,9249.8%
Vaxcyte Inc(PCVX)COM92243G108$127.2M2,188,6366.0%
Exelixis Inc(EXEL)COM30161Q104$84.5M1,553,2624.0%
Tango Therapeutics Inc(TNGX)COM87583X109$78.2M2,500,1033.7%
Avalo Therapeutics Inc(AVTX)COM NEW05338F306$58.5M3,163,8662.8%
Xenon Pharmaceuticals Inc(XENE)COM98420N105$53.7M889,9442.5%
Adma Biologics Inc(ADMA)COM000899104$47.9M5,725,0072.3%
Revolution Medicines Inc(RVMD)CallCOM76155X100$47.2M251,8002.2%
LB Pharmaceuticals Inc(LBRX)COM SHS50180M108$46.7M1,438,0702.2%
Immunocore Hldgs PLC(IMCR)ADS45258D105$43.9M1,381,3172.1%
Viridian Therapeutics Inc(VRDN)COM92790C104$40.3M2,193,9811.9%
VOR Biopharma Inc(VOR)COM NEW929033207$35.4M1,925,0661.7%
SAB Biotherapeutics Inc(SABS)COM NEW78397T202$31.1M7,967,2071.5%
Inventiva SA(IVA)ADS46124U107$30.9M8,163,1911.5%
Aura Biosciences Inc(AURA)COM05153U107$30.5M4,298,2481.4%
Tyra Biosciences Inc(TYRA)COM90240B106$25.8M806,9861.2%
Opus Genetics Inc(IRD)COM67577R102$25.0M6,077,0841.2%
Anika Therapeutics Inc(ANIK)COM035255108$21.0M1,435,1301.0%
Sagimet Biosciences Inc(SGMT)COM SER A786700104$19.3M2,500,0000.9%
Artiva Biotherapeutics Inc(ARTV)COM04317A107$16.8M1,736,1110.8%
Faeth Therapeutics Inc(SNSE)COM NEW81728A207$15.7M629,4670.7%
MBX Biosciences Inc(MBX)COM55287L101$11.0M200,0000.5%
Verrica Pharmaceuticals Inc(VRCA)COM SHS92511W207$5.7M923,9100.3%
Agios Pharmaceuticals Inc(AGIO)CallCOM00847X104$3.3M90,0000.2%
Adma Biologics Inc(ADMA)CallCOM000899104$2.5M300,0000.1%
Cellectar Biosciences Inc(CLRB)COM NEW15117F880$1.3M469,9980.1%